... Food and Drug Administration (FDA) include: Axicabtagene ciloleucel (Yescarta), approved to treat some types of non-Hodgkin lymphoma Brexucabtagene autoleucel (Tecartus), approved for adults with relapsed or refractory B-cell ALL Obecabtagene autoleucel (Aucatzyl), approved for adults with relapsed or refractory B-cell precursor ALL Tisagenlecleucel ...
8 Leukemia Treatment Options You Should Know
... Food and Drug Administration (FDA) include: Axicabtagene ciloleucel (Yescarta), approved to treat some types of non-Hodgkin lymphoma Brexucabtagene autoleucel (Tecartus), approved for adults with relapsed or refractory B-cell ALL Obecabtagene autoleucel (Aucatzyl), approved for adults with relapsed or refractory B-cell precursor ALL Tisagenlecleucel ...